Tachibana Aaron reported option exercise involving 38,799 derivative units of Personalis, Inc. at $0.00 for $0 on May 29, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CFO AND COO
CFO AND COO
Filed May 29, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
38,799Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
68,832Direct
Trade date
May 29, 2026Option exercise
Filed
May 29, 2026, 8:27 PM ET1-day reporting delay
Accession
0001401786-26-000004Code M · Transaction 94611
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 29, 2026Option exercise38,799$9.16$355,398.84Trade 94609
May 29, 2026Sell38,799$11.58−$449,292.42Trade 94610
3 transaction rows in this filing. Joint filers share the same rows.

PSNL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PSNL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −56%1w ago −26%1d ago −3.7%
Returns since7d −5.7%30d +21%90d180d1y

Footnotes in full

F1: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025. F2: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $11.50 to $11.71 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3: The shares subject to the option are fully vested and exercisable.